|
|
|
|
|
|
|
|
Hereditary Cancer in Clinical Practice | Full Text
Table of Contents
Without preventive measures, the development of CRC amongst LS affected individuals is estimated at a lifetime risk of 10 – 74%, depending on sex and the MMR gene mutated [2, 3]. Female carriers are also at an increased risk of gynaecological cancers (GC), with an estimated lifetime risk for endometrial cancer of 14 – 71%, and 4 – 20% for ovarian cancer [2, 3].Results
Thirty-three people were interviewed. Of the non-carriers (n = 16),
2 reported having apparently unnecessary colonoscopies, and 6 were
unsure about what population-based colorectal cancer screening entails.
Of the carriers (n = 17), 2
reported they had not had regular colonoscopies, and spoke about their
discomfort with the screening process and a lack of faith in the
procedure’s ability to reduce their risk of developing colorectal
cancer. Of the female carriers (n = 9), 2 could not recall being informed about the associated risk of gynaecological cancers.
Conclusion
Non-carriers and female
carriers of Lynch syndrome could benefit from further clarity and advice
about appropriate risk management options. For those carriers who did
not adhere to colonoscopy screening, a lack of faith in both genetic
test results and screening were evident. It is essential that consistent
advice is offered to both carriers and non-carriers of Lynch syndrome.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.